Cardiorespiratory effects of hypertonic glucose in the critically ill patient.
D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D005260:Female; D005947:Glucose / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D006334:Heart Function Tests; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006982:Hypertonic Solutions; D007263:Infusions, Parenteral; D008297:Male; D008353:Mannitol / Q000008:administration & dosage / Q000494:pharmacology; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D012119:Respiration / Q000187:drug effects*; D012129:Respiratory Function Tests; D014655:Vascular Resistance / Q000187:drug effects
D006982:Hypertonic Solutions; D008353:Mannitol; D005947:Glucose; D010100:Oxygen